Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a publicly traded Healthcare sector company. As of November 5, 2026, OBIO trades at $5.02 with a market cap of $360.63M and a P/E ratio of -5.24. OBIO moved -6.25% today. Year to date, OBIO is +32.43%; over the trailing twelve months it is +43.24%. Its 52-week range spans $2.20 to $6.50. Analyst consensus is strong buy with an average price target of $11.60. Rallies surfaces OBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for OBIO, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $5.02 |
| Market Cap | $360.63M |
| P/E Ratio | -5.24 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.50 |
| 52-Week Low | $2.20 |
| Volume | 187.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $33.48M |
| Net Income | $-52.70M |
| Gross Margin | 99.43% |
5 analysts cover OBIO: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.60.